Filing Details

Accession Number:
0001209191-10-004831
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-26 12:00:00
Reporting Period:
2010-01-22
Filing Date:
2010-01-26
Accepted Time:
2010-01-26 15:58:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1272353 David Lawrence 15 Skyline Drive
Hawthorne NY 10532
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-01-22 5,000 $8.14 15,800 No 4 M Direct
Common Stock Disposition 2010-01-22 5,000 $28.00 10,800 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2010-01-22 5,000 $8.14 4,000 $8.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
44,109 2005-08-03 2015-01-01 No 4 M Direct
Footnotes
  1. Exercise and sale pursuant to a 10b5-1 plan.